chr16-81927353-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002661.5(PLCG2):c.2514+175G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.159 in 152,136 control chromosomes in the GnomAD database, including 2,457 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2457 hom., cov: 31)
Consequence
PLCG2
NM_002661.5 intron
NM_002661.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.554
Publications
7 publications found
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]
PLCG2 Gene-Disease associations (from GenCC):
- autoinflammation-PLCG2-associated antibody deficiency-immune dysregulationInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
- familial cold autoinflammatory syndrome 3Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-81927353-G-C is Benign according to our data. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81927353-G-C is described in CliVar as Benign. Clinvar id is 1183021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLCG2 | NM_002661.5 | c.2514+175G>C | intron_variant | Intron 23 of 32 | ENST00000564138.6 | NP_002652.2 | ||
PLCG2 | NM_001425749.1 | c.2514+175G>C | intron_variant | Intron 24 of 33 | NP_001412678.1 | |||
PLCG2 | NM_001425750.1 | c.2514+175G>C | intron_variant | Intron 23 of 32 | NP_001412679.1 | |||
PLCG2 | NM_001425751.1 | c.2514+175G>C | intron_variant | Intron 24 of 33 | NP_001412680.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.159 AC: 24173AN: 152018Hom.: 2458 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
24173
AN:
152018
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.159 AC: 24171AN: 152136Hom.: 2457 Cov.: 31 AF XY: 0.157 AC XY: 11642AN XY: 74388 show subpopulations
GnomAD4 genome
AF:
AC:
24171
AN:
152136
Hom.:
Cov.:
31
AF XY:
AC XY:
11642
AN XY:
74388
show subpopulations
African (AFR)
AF:
AC:
2359
AN:
41516
American (AMR)
AF:
AC:
2013
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
803
AN:
3470
East Asian (EAS)
AF:
AC:
146
AN:
5192
South Asian (SAS)
AF:
AC:
490
AN:
4814
European-Finnish (FIN)
AF:
AC:
2461
AN:
10576
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15248
AN:
67978
Other (OTH)
AF:
AC:
330
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
985
1970
2954
3939
4924
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
283
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.